The shift between an AR signal mainly associated with epithelial growth and differentiation to signaling associated with indiscriminate growth in the cancer scenario is unclear; nonetheless, although this AR pathway is the cornerstone of current therapies, resistance arises in the context of androgen deprivation therapy (ADT) and androgen blockade[128,129]. This evidence concerns the gene AR and cancer.